| Identification | More | [Name]
Eflornithine hydrochloride | [CAS]
68278-23-9 | [Synonyms]
2-(Difluoromethyl)-DL-ornithine monohydrochloride
2-(DIFLUOROMETHYL)-ORNITHINE HYDROCHLORIDE
DFMO
DFMO HCL
DFMO HYDROCHLORIDE
DL-ALPHA-DIFLUOROMETHYLORNITHINE HYDROCHLORIDE
EFLORNITHINE HCL
EFLORNITHINE HYDROCHLORIDE
RMI-71782
RMI-71782 HYDROCHLORIDE
2-(difluoromethyl)-dl-ornithinehydrochloridehydrate
alpha-difluoromethylornithinehydrochloridehydrate
dl-ornithine,2-(difluoromethyl)-,monohydrochloride,hydrate
eflornithinehydrochloridehydrate
DL-alpha-Difluoromethylonithine
EflornitineHCl
Eflornitinehydrochloride
2-(Difluoromethyl)-DL-Ornithine hydrochloride | [EINECS(EC#)]
269-532-0 | [Molecular Formula]
C6H13ClF2N2O2 | [MDL Number]
MFCD00274036 | [Molecular Weight]
218.63 | [MOL File]
68278-23-9.mol |
| Hazard Information | Back Directory | [Uses]
Antineoplastic; antiprotozoal. | [Uses]
DL-alpha-Difluoromethylornithine Hydrochloride is an irreversible inhibitor of ornithine decarboxylase. | [Indications]
Vaniqa (eflornithine hydrochloride 13.9%) cream is a unique topical cream
that slows anagen hair growth by irreversibly blocking the enzyme ornithine
decarboxylase. This enzyme produces polyamines in the hair matrix that are
partially responsible for the growth of the anagen hair. The cream was tested
only on the upper lip and chin region. The onset of action is usually within 8
weeks of starting the b.i.d. treatment, and the hair growth will return to baseline
within 8 weeks of discontinuing the drug. Patients need to be reminded that this
product does not remove hair but slows its growth in between whatever they use
for hair removal. | [Brand name]
Ornidyl (Sanofi Aventis); Vaniqa (Skinmedica). | [in vivo]
Eflornithine is the only new molecule registered for the treatment of human African trypanosomiasis over the last 50 years. It is the drug used mainly as a back-up for melarsoprol refractory Trypanosoma brucei gambiense cases[1]. In subjects with excessive, unwanted facial hair, eflornithine 15% cream is superior to placebo in reducing hair growth. After 24 weeks' treatment, 58% of eflornithine and 34% of placebo subjects have at least some improvement in facial hirsutism[2]. The hair growth inhibitory activity of eflornithine is significantly enhanced when the eflornithine cream is applied onto a mouse skin area pretreated with microneedles[3]. Treatment of coarctation hypertensive rats with eflornithine results in a normalization of the contractile intensity to KCI and norepinephrine and relaxations to acetylcholine by 14 days of hypertension[4]. | [IC 50]
Trypanosoma | [storage]
Store at -20°C |
|
|